为了推进科研院所、企业界和投资界在PROTAC药物研发领域内的交流与合作，5月16日，由免疫化学研究所主办的首届PROTAC药物发现与开发前沿论坛（Symposium on Frontier in PROTAC Drug Discovery and Development）在我校会议中心成功举办。 查看详细
近日，上海科技大学免疫化学研究所特聘教授蒋华良院士团队在Journal of Medicinal Chemistry发表封面文章Pushingthe Boundaries of Molecular Representation for Drug Discovery with the GraphAttention Mechanism，介绍了一种基于注意力机制的图神经网络模型(Attentive FP）。
查看详细
近期，上海科技大学免疫化学所抗体化学实验室与分析化学平台合作，开发出新型交联剂（cross-linker），用于化学交联质谱（XL-MS）分析。该研究成果以“A novel mass spectrometry-cleavable, phosphate-based enrichable and multi-targeting protein cross-linker”为题，于2019年5月23日在英国皇家化学会旗舰期刊《chemical science》上以Edge Article的形式在线发表，并入选年度热点论文（HOT Article Collection）。查看详细
近日，上海科技大学免疫化学研究所Richard Lerner教授和杨光教授研究团队合作，研制出富含天然产物的新一代DNA编码化合物库（DNA-Encoded Library, DEL），以《Functionality-Independent DNA Encoding of Complex Natural Products》为题发表在国际顶级化学期刊Angewandte Chemie International Edition。查看详细
信息来源：Prof. Jacques Neefjes
时间：10:00AM, Sep 17th（Tuesday), 2019
The anthracycline doxorubicin (Doxo) is one of the most effective and commonly used anti-cancer drugs. However, its clinical application is limited by severe side effects, such as cardiotoxicity, therapy-related tumors and infertility. Doxo induces both DNA damage through double-strand breaks and chromatin damage through histone eviction. We examined ...查看详细
The three Life Science Organizations of ShanghaiTech University (School of Life Science and Technology, SLST, Shanghai Institute of Advanced Immunochemical Science, SIAIS, and iHuman Institute) will join efforts to organize a joint Bioforum on November 10-14, 2019.查看详细
Neuroergonomics is an emerging field that investigates the human brain in relation to behavioral performance in natural environments and everyday settings. Neuroergonomics research aims to expand our understanding of the neural mechanisms underlying human perceptual, cognitive, and motor functioning with a focus on real-world contexts......查看详细
信息来源：Invited and hosted by Prof. Biao Jiang
时间：2:00 pm, June. 21st (Friday), 2019
Dr. Luo started his independent laboratory at Memorial Sloan Kettering Cancer Center and at Weill Medical School of Cornell University in 2008. At the interface of chemistry and biology, the long-term goal of the Luo laboratory is to combine chemical and biological approaches to define, perturb and manipulate functions of diverse epigenetic modulators for disease diagnosis and therapy.查看详细
